July 26, 2026
avatar-torie-bosch
First Opinion editor

I haven’t seen “The Odyssey” yet, but as a Latin minor who dabbled in Hellenism, I perked up when a brilliant piece of writing about the movie landed in my inbox this week. Elizabeth Dray, a urologist, connects the film and masculinity mythology to the recent announcement that the Pentagon will screen the testosterone levels of all servicemembers over 30. “The poet didn’t say ‘sing to me, Muse, of a man with optimized endocrine panels,’” she writes. I am a sucker for a piece that joins health policy, pop culture, and the Classics.

Recommendation of the week: If you’re interested in science journalism — and if you’re reading STAT, you must be! — don’t miss “The Best Science Stories and How They Work,” out now from the University of Chicago Press. It’s a compilation of some of the best science reporting from recent years, from outlets like Nature, The Atlantic, and The New York Times Magazine, annotated, with a Q&A with each author about how they reported and wrote the piece. It’s edited by Siri Carpenter, co-founder of The Open Notebook, the best resource out there for science journalists. (I’m biased — I was a senior editor there for several years — but I said that long before they started paying me.)



Adobe

My husband’s suicide shows there’s something very wrong with the U.S. insurance industry

Six days into an eight-week stay at an inpatient psychiatric facility, insurance denied Joy Evers’ husband’s claim. The story does not have a happy ending.

By Joy Evers


I may be one of the last middle-class medical students who could afford to become a doctor

Federal student loan changes will keep many students from medical school, just as physician shortages become more acute.

By Gauri Gurumurthy


The U.S. pharmaceutical supply chain problem is not about China

The root cause of U.S. pharmaceuticals supply chain vulnerabilities is inadequate regulation of an industry that tends to prioritize profit.

By Pooja Yerramilli


Adobe

New billing codes likely to raise maternity care costs

There is every reason to believe that this change will result in cost increases for employer-sponsored health plans and Medicaid programs.

By Jeff Levin-Scherz


Good riddance to bundled ‘global’ maternal care billing

Bundled obstetric payments have complicated billing, limited access to care, and hurt research initiatives.

By Camille A. Clare and Lisa G. Hofler


What Argentina’s World Cup loss should teach American hospitals

American hospitals are particularly vulnerable to the mythology of the indispensable physician or leader: the renowned surgeon, brilliant diagnostician.

By Basel Tarab


Adobe

STAT+ | Hospitals’ AI may be drifting. Who’s watching?

The health systems that get durable value from AI will be the ones that move fast and can prove their AI is still safe, equitable, and effective.

By Peter Pronovost, Justin Norden, and Kedar Mate


STAT+ | I’m a cardiologist. I’m not sure the new cholesterol drug enlicitide is a game-changer

The data on downstream cardiovascular outcomes for Merck’s Lipfendra (enlicitide) are still pending, cardiologist writes.

By Vishal Khetpal


Pete Hegseth, ‘The Odyssey,’ and the testosterone myth

While concerns over testosterone levels are new, anxiety about manliness is ancient. A STAT First Opinion essay on why masculinity isn't measured in a lab.

By Elizabeth Dray


Adobe

How a controversial rule could hurt the NIH’s ability to manage risk

Excluding external researchers from science oversight is especially ill-advised today, when we face novel, explosive ethical questions in science.

By Doni Bloomfield


Science and the public are learning the wrong lessons from Covid

Two studies conclude nonpharmaceutical interventions had little or no effect in reducing Covid deaths before vaccines. Both make critical errors.

By Marc Lipsitch and Sara Cody


More around STAT

 
STAT
STAT, 1 Exchange Place, Boston, MA
©2026, All Rights Reserved.